Breaks Categories: News

FridayDec 03, 2021 3:33 pm

NetworkNewsBreaks – Culp, Inc. (NYSE: CULP) Featured in Research Note from Sidoti

Price Target Lowered; Earnings Release; Estimates Lowered Culp, Inc. (NYSE: CULP) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “2Q:F22 Results In-Line With Pre-Release; Adjusted EPS Estimates Still Imply Solid Rebound In 4Q:F22-F2023; Maintain Moderately Risky Rating, Trim Price Target To $20 (From $22).” Click here to access the full report. About Culp, Inc. Culp is one of the world’s largest marketers of mattress fabrics for bedding and upholstery fabrics for residential and commercial furniture. The company markets a variety of fabrics to its global customer base of leading bedding…

Continue Reading

FridayDec 03, 2021 1:44 pm

NetworkNewsBreaks – STRATTEC SECURITY CORP. (NASDAQ: STRT) Featured in Research Note from Sidoti

Estimates Lowered; Corporate Update STRATTEC SECURITY (NASDAQ: STRT) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “COVID Resurgence And Ongoing Supply Chain Constraints Temper Our Profit Expectations; Maintain $65 Price Target.” Click here to access the full report. About STRATTEC SECURITY CORP. STRATTEC designs, develops, manufactures, and markets automotive Access Control Products, including mechanical locks and keys, electronically enhanced locks and keys, steering column and instrument panel ignition lock housings, latches, power sliding side door systems, power lift gate systems, power deck lid systems, door handles and related products. These…

Continue Reading

FridayDec 03, 2021 1:28 pm

NetworkNewsBreaks – GEO Group Inc. (NYSE: GEO) Featured in Research Note from Sidoti

Estimates Lowered; Corporate Update GEO Group Inc. (NYSE: GEO) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “We View Change In Corporate Structure As A Long-Term Positive; Lower EPS Estimates To Reflect The Resulting Higher Tax Rate; Maintain Moderately Risky Rating, $15 Price Target.” Click here to access the full report. About GEO Group Inc. The Geo Group is a real estate investment trust that specializes in the ownership, lease, and management of correctional, detention, and re-entry facilities. U.S. Corrections and Detention (67% of 2020 revenue) encompasses United States based…

Continue Reading

FridayDec 03, 2021 1:15 pm

NetworkNewsBreaks – MoneyShow’s Upcoming Expo to Showcase Innovative Ways for Accredited Investors to Generate Wealth

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, will be hosting the upcoming MoneyShow Accredited Investors Expo. Set to take place in an entirely digital format on Dec. 7-9, 2021, the event will feature some of the industry’s most sought-after experts from across the North American continent to share innovative ways by which accredited investors can generate wealth. The Virtual Expo will feature a strong lineup of market experts, including more than 30 leading speakers, and provide information and tools accredited investors need to increase success. These include learning tips on investing in…

Continue Reading

FridayDec 03, 2021 12:33 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Beginning of Validation Process for Class 2 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has started the initial validation testing of its exclusive Class 2 EV cargo van. The testing is taking place at Mullen’s Advanced Manufacturing and Engineering Center (“AMEC”), which is located in Tunica, Mississippi. Based on a 144-inch wheelbase, Mullen’s Class 2 EV cargo van features a 78.8-kWh battery pack as well as rear-wheel drive and a  modular 460-cubic-foot cargo area. In addition, the vehicle offers a range of more than 200 miles and a maximum payload of 3,296 pounds. “Our Class 2 EV cargo van initial validation testing has begun…

Continue Reading

FridayDec 03, 2021 11:47 am

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Announces Participation in December 2021 Conferences

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, will be featured in several upcoming conferences. The company announced that president and CEO Kelsey Ramsden has been invited to present in four virtual conferences scheduled in December. Those conferences include the H.C. Wainwright's second annual Psychedelics Conference, the Psychedelics Now Virtual Conference, the #CanndoraConnect: Women in Psychedelics Conference, and the Life Sciences Investor Forum. The H.C. Wainwright Psychedelics Conference is scheduled for Dec. 6, 2021; Ramsden’s presentation will begin at 7 a.m. The Psychedelics Now Virtual Conference will be held…

Continue Reading

FridayDec 03, 2021 11:31 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at 2nd Annual H.C. Wainwright Psychedelics Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present at the Second Annual H.C. Wainwright Psychedelics Conference. The event is slated to be held virtually on Dec. 6, 2021. Tryp’s chairman and CEO Greg McKee will provide an overview of the business and its pipeline, including the upcoming phase 2a clinical trials in fibromyalgia, phantom limb pain, binge eating disorder and other indications. McKee's presentation will be available on-demand through the H.C. Wainwright conference portal beginning at 7:00 a.m. ET. on Monday, Dec.…

Continue Reading

FridayDec 03, 2021 9:39 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Upcoming Sequire Clean Tech & EV Virtual Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will be hosting the first-ever Sequire Clean Tech & EV Conference. The investor event will be held on Dec. 6, 2021. This premier gathering is designed to feature a variety of companies, including those in the EV, energy and power, materials and chemicals, and food and agriculture industries. Green energy and sustainability are becoming top priorities in today’s world, and this inaugural gathering is designed to create an invaluable opportunity for premier innovators in the clean-tech space to…

Continue Reading

FridayDec 03, 2021 9:30 am

NetworkNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) Lucid-MS Featured in InvestmentPitch Video, CEO to Present at H.C. Wainwright Psychedelics Virtual Conference

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today shared preclinical data demonstrating the potentially disease-modifying effects of Lucid-MS, its lead drug candidate for the potential treatment of multiple sclerosis in the animal models of MS. According to the update, InvestmentPitch.com has produced a video discussing the news. Based on over a decade of research, Lucid-MS is a patented neuroprotective new chemical entity that affects protein citrullination and myelin structure, which are associated with the severity of MS lesions. FSD Pharma has released a video…

Continue Reading

ThursdayDec 02, 2021 12:04 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Switzerland Ethics Committee Approval of Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received approval from the Switzerland Ethics Committee (swissethics) — the first approval of its kind from a European ethics committee — for its study of Berubicin. Exclusive to CNS Pharmaceuticals, Berubicin is the first anthracycline that appears to cross the blood-brain barrier; the substance is being assessed in a global study designed to evaluate efficacy and safety in the treatment of recurrent glioblastoma multiforme (“GBM”). The adaptive, multicenter, open-label, randomized and controlled study…

Continue Reading